1. Home
  2. COLL vs HLIT Comparison

COLL vs HLIT Comparison

Compare COLL & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • HLIT
  • Stock Information
  • Founded
  • COLL 2002
  • HLIT 1988
  • Country
  • COLL United States
  • HLIT United States
  • Employees
  • COLL N/A
  • HLIT N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • COLL Health Care
  • HLIT Technology
  • Exchange
  • COLL Nasdaq
  • HLIT Nasdaq
  • Market Cap
  • COLL 958.8M
  • HLIT 1.0B
  • IPO Year
  • COLL 2015
  • HLIT 1995
  • Fundamental
  • Price
  • COLL $31.60
  • HLIT $9.30
  • Analyst Decision
  • COLL Strong Buy
  • HLIT Buy
  • Analyst Count
  • COLL 4
  • HLIT 6
  • Target Price
  • COLL $43.75
  • HLIT $12.30
  • AVG Volume (30 Days)
  • COLL 291.1K
  • HLIT 1.4M
  • Earning Date
  • COLL 08-07-2025
  • HLIT 07-28-2025
  • Dividend Yield
  • COLL N/A
  • HLIT N/A
  • EPS Growth
  • COLL N/A
  • HLIT N/A
  • EPS
  • COLL 1.25
  • HLIT 0.44
  • Revenue
  • COLL $664,283,000.00
  • HLIT $689,797,000.00
  • Revenue This Year
  • COLL $20.23
  • HLIT N/A
  • Revenue Next Year
  • COLL $3.82
  • HLIT $21.74
  • P/E Ratio
  • COLL $25.23
  • HLIT $20.93
  • Revenue Growth
  • COLL 17.17
  • HLIT 20.53
  • 52 Week Low
  • COLL $23.23
  • HLIT $7.91
  • 52 Week High
  • COLL $42.29
  • HLIT $15.46
  • Technical
  • Relative Strength Index (RSI)
  • COLL 61.58
  • HLIT 51.00
  • Support Level
  • COLL $31.53
  • HLIT $8.91
  • Resistance Level
  • COLL $32.95
  • HLIT $9.52
  • Average True Range (ATR)
  • COLL 0.88
  • HLIT 0.36
  • MACD
  • COLL 0.06
  • HLIT -0.03
  • Stochastic Oscillator
  • COLL 73.51
  • HLIT 40.29

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: